Rubric Capital Management (New York)’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230M | Buy |
20,370,336
+2,603,260
| +15% | +$29.3M | 3.47% | 6 |
|
|
2025
Q1 | $179M | Sell |
17,767,076
-2,232,924
| -11% | -$22.5M | 3.21% | 7 |
|
|
2024
Q4 | $237M | Sell |
20,000,000
-2,400,000
| -11% | -$28.4M | 3.04% | 6 |
|
|
2024
Q3 | $258M | Sell |
22,400,000
-600,000
| -3% | -$6.92M | 4.21% | 3 |
|
|
2024
Q2 | $243M | Buy |
23,000,000
+3,000,000
| +15% | +$31.7M | 6.37% | 2 |
|
|
2024
Q1 | $211M | Buy |
20,000,000
+1,000,000
| +5% | +$10.5M | 6.23% | 3 |
|
|
2023
Q4 | $213M | Buy |
19,000,000
+8,500,000
| +81% | +$95.5M | 4.43% | 1 |
|
|
2023
Q3 | $123M | Buy |
10,500,000
+6,963,562
| +197% | +$81.3M | 4.6% | 4 |
|
|
2023
Q2 | $35.6M | Sell |
3,536,438
-2,063,562
| -37% | -$20.8M | 1.52% | 28 |
|
|
2023
Q1 | $41.3M | Buy |
5,600,000
+2,600,000
| +87% | +$19.2M | 1.07% | 20 |
|
|
2022
Q4 | $24M | Buy |
+3,000,000
| New | +$24M | 1.05% | 32 |
|